Global Messenger RNA Vaccines and Therapeutics Supply, Demand and Key Producers, 2023-2029

Global Messenger RNA Vaccines and Therapeutics Supply, Demand and Key Producers, 2023-2029

The global Messenger RNA Vaccines and Therapeutics market size is expected to reach $ 22370 million by 2029, rising at a market growth of 12.1% CAGR during the forecast period (2023-2029).

An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.

This report studies the global Messenger RNA Vaccines and Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Messenger RNA Vaccines and Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Messenger RNA Vaccines and Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Messenger RNA Vaccines and Therapeutics total market, 2018-2029, (USD Million)

Global Messenger RNA Vaccines and Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Messenger RNA Vaccines and Therapeutics total market, key domestic companies and share, (USD Million)

Global Messenger RNA Vaccines and Therapeutics revenue by player and market share 2018-2023, (USD Million)

Global Messenger RNA Vaccines and Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)

Global Messenger RNA Vaccines and Therapeutics total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Messenger RNA Vaccines and Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Kline's, Daiichi Sankyo Company, Intellia Therapeutics, Arcturus Therapeutics and Emmy Vaccine, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Messenger RNA Vaccines and Therapeutics market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Messenger RNA Vaccines and Therapeutics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Messenger RNA Vaccines and Therapeutics Market, Segmentation by Type
Self-amplifying
Conventional Non-amplifying

Global Messenger RNA Vaccines and Therapeutics Market, Segmentation by Application
Cancer
Infectious Diseases
Autoimmune Diseases
Others

Companies Profiled:
BioNTech
Moderna
CureVac
Pfizer
Glaxo Smith Kline's
Daiichi Sankyo Company
Intellia Therapeutics
Arcturus Therapeutics
Emmy Vaccine
CSPC
CanSino
Fosun Pharma

Key Questions Answered

1. How big is the global Messenger RNA Vaccines and Therapeutics market?

2. What is the demand of the global Messenger RNA Vaccines and Therapeutics market?

3. What is the year over year growth of the global Messenger RNA Vaccines and Therapeutics market?

4. What is the total value of the global Messenger RNA Vaccines and Therapeutics market?

5. Who are the major players in the global Messenger RNA Vaccines and Therapeutics market?

6. What are the growth factors driving the market demand?